LIPT1, an enzyme that activates 2-ketoacid dehydrogenases related to the TCA cycle and promotes cuproptosis (Solmonson and DeBerardinis, 2018), has been reported the association with the prognosis of urothelial carcinoma and lung cancer in the Pathology Atlas project (Uhlen et al., 2017). This evidence concerns the gene LIPT1 and lung carcinoma.